ArticleDrug design, development and therapy2026

First-in-Human Study of the PARP Inhibitor HWH340 in Advanced Solid Tumors with Enrichment for Homologous Recombination Repair Gene Mutations.

Jie Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.